Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Rare Cancers Europe is a finalist for a Thematic Network under the EU Health Policy Platform of the European Commission

28 Jul 2021

On 7 June, the European Commission (EC) opened a call for proposals for the 2021 Thematic Networks under the EU Health Policy Platform. The EC’s Health Policy Platform hosts a range of Thematic Networks, whose aim is to work with their communities and create Joint Statements that support the various policy initiatives being developed at EU level. Thematic Networks are designed to discuss health issues, share ideas, and gather information on policy areas related to health.

This year, Rare Cancers Europe responded to the call for proposals for the creation of a new Thematic Network dedicated to rare cancers. Despite the increased focus on oncology at European level, rare cancers are still a neglected area deserving attention across all policies as well as on-going and planned initiatives.

The European Commission selected the RCE proposal “Rare Cancers in All Policies” as one of the 5 semi-finalists and it then opened a “competition” between the 5 shortlisted proposals through a polling exercise with the aim to select the top 3 proposals.

The polling exercise closed on the 26 of July at 23:59 and the RCE proposal received the second highest number of votes putting it in second place. If you are a registered member of the Health Platform, you can have access to the result of the votes here.

The European Commission will now deliberate and choose the winners in three different policy areas based on the highest number of votes.

For more information regarding RCE’s proposal please click here.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings